|
Real-time Estimate
Cboe Europe
10:51:09 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 119.70 SEK | -1.40% |
|
-7.27% | +12.90% |
| 10-28 | Biogaia's Vice Chairman David Dangoor Sells Shares for SEK 19m | FW |
| 10-23 | SB1 Markets downgrades Biogaia to neutral, raises target price | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.24B | |||||
| 1,148B | |||||
| 652B | |||||
| 505B | |||||
| 384B | |||||
| 348B |
- Stock Market
- Stocks
- BIOG B Stock
- Charts BioGaia AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
